22nd Workshop, Brussels: “Rare Diseases: Going Global”
“Rare Diseases: Going Global”
February 25th, 2015
In the current climate, the development of innovative rare disease therapies is mostly global in nature due to the rarity of patients and experts, as well as to the fact that companies and investors have an increasingly international approach to the market. The meeting’s objective was to discuss the opportunities that ‘going international’ presents, as well as to look at possible approaches for a long-term, structured, progressive internationalisation that involves patients, patient organisations, researchers, industry and competent authorities.
For ERTC Members only, this document is password protected. If you want to become a member, find out more here or contact Anne-Mary Bodin, Operations Assistant.